Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.07.2021 | Case report

Everolimus/lenvatinib

Heart failure, increased creatinine and urea levels and pulmonitis with pneumonia: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Volkova MI, et al. Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: Secondary analysis of data obtained in the russian multicenter observational study. Onkourologiya 17: 31-44, No. 1, 2021. Available from: URL: https://oncourology.abvpress.ru/oncur/article/view/1440 [Russian; summarised from a translation] Volkova MI, et al. Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: Secondary analysis of data obtained in the russian multicenter observational study. Onkourologiya 17: 31-44, No. 1, 2021. Available from: URL: https://​oncourology.​abvpress.​ru/​oncur/​article/​view/​1440 [Russian; summarised from a translation]
Metadaten
Titel
Everolimus/lenvatinib
Heart failure, increased creatinine and urea levels and pulmonitis with pneumonia: 3 case reports
Publikationsdatum
01.07.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-99090-2

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Vinorelbine

Case report

Temozolomide

Case report

Multiple drugs

Case report

Antineoplastics